The safety and efficacy of cannabis-based products depend on an integrated chain involving chemists, biomedicals, pharmacists, and doctors — professionals who ensure, at each stage, the quality, stability, and trust in patient treatment

Bipartisan proposal considers that the already consolidated market can be controlled by clear rules, instead of being banned in the state

Coalition accuses retailers of selling marijuana as hemp and operating outside the regulated market

Proposal authorizes companies to cultivate plants with up to 0.3% THC exclusively for the production of medicinal inputs, but experts warn of the technical unfeasibility of the limit in a tropical climate

Scientific Committee maintains technical rigor and focuses on a forward-looking program in the 5th edition of the event in São Paulo

The experiment aims to expose plants to microgravity for nine months following a capsule recovery failure in 2025

Proposal creates a legal framework for production, importation, and self-cultivation; the report included strict security requirements for the medicinal use of cannabis

While the global index declines, the ETF MSOS accumulates significant gains in 2025, driven by expectations of changes in Section 280E

Financial contributions from major companies in the sector occurred months before the president's executive measure, aiming for a change in federal legislation

Agency presents new report without a defined timeline, while experts warn that a change to Schedule III would have profound impacts on research and taxation, but not federal legalization

Global Index falls by 4.2% during the year, but American operators diverge from the global scenario and show significant growth

Specialist details how MDMA acts in the brain and the promising results in patients resistant to conventional therapies

Partnership with startup Buds INC investigates the physical and chemical properties of the material to extend the lifespan and resistance of recyclable products

Research with elite competitors points to effectiveness in recovery, but warns of risks of accidental doping in CBD use

Digitization is driving the cannabis sector, but requires new precautions to keep data and operations protected

End of the Farm Bill shutdown in the US exposes Brazil's vulnerability due to lack of cultivation and lack of productive autonomy to ensure self-sufficiency

Lead singer comments on market advancements, criticizes historical roots of prohibition, and urges users to take a proud stance

Global sector reaches record $6.8 trillion, with a 26% growth highlighted in cannabis-based products in the North American scenario

Governor confirms that Furp will be responsible for the production of plant-based medications, amid announcement of R$ 379 million for municipal health

After four editions as Medical Cannabis Fair, the event takes on a new positioning, changes its name to Cannabis Fair, and launches an official website focusing on the entire production chain of the plant